BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3470539)

  • 1. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
    Rose DP; Boyar AP; Cohen C; Strong LE
    J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet, serum, breast fluid growth hormone, and prolactin levels in normal premenopausal Finnish and American women.
    Rose DP; Boyar AP; Kettunen K
    Nutr Cancer; 1988; 11(3):179-87. PubMed ID: 2841652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease.
    Rose DP; Berke B; Cohen LA; Lahti H
    Cancer; 1987 Dec; 60(11):2761-5. PubMed ID: 3119186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and breast cancer risk.
    Ingram DM; Nottage EM; Roberts AN
    Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-fat diet on female sex hormone levels.
    Ingram DM; Bennett FC; Willcox D; de Klerk N
    J Natl Cancer Inst; 1987 Dec; 79(6):1225-9. PubMed ID: 3480374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and growth factors in nipple aspirates from normal women and benign breast disease patients.
    Rose DP
    Cancer Detect Prev; 1992; 16(1):43-51. PubMed ID: 1551137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S; Andersen AN; Blichert-Toft M
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-fat intake on lactogenic hormone bioactivity in premenopausal women.
    Shultz TD; Rose DP
    Am J Clin Nutr; 1988 Sep; 48(3 Suppl):791-4. PubMed ID: 3414587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a low-fat diet on hormone levels in women with cystic breast disease.
    Smith CJ
    J Natl Cancer Inst; 1987 Sep; 79(3):607. PubMed ID: 3476798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J; Rebhan EM; Prestele H; Becker H
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.
    Secreto G; Recchione C; Fariselli G; Di Pietro S
    Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study).
    Gann PH; Chatterton RT; Gapstur SM; Liu K; Garside D; Giovanazzi S; Thedford K; Van Horn L
    Cancer; 2003 Nov; 98(9):1870-9. PubMed ID: 14584069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive and immunoactive prolactin levels after TRH-stimulation in the sera of normal women.
    Maddox PR; Jones DL; Mansel RE
    Horm Metab Res; 1992 Apr; 24(4):181-4. PubMed ID: 1601394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.